Wall Street Analysts Believe Schrodinger (SDGR) Could Rally 46.17%: Here's is How to Trade

The consensus price target hints at a 46.2% upside potential for Schrodinger (SDGR). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zacks Investment Research • Dec 12, 2025

Unlocking Hidden Value In Schrodinger's Box

Schrodinger's shares have declined sharply in recent weeks, due largely to soft guidance for the fourth quarter. There is little reason to believe that this is anything more than a temporary headwind caused by market conditions though. In addition, recent cost reductions and the end of internal drug development should significantly reduce cash burn in 2026.

Seeking Alpha • Dec 2, 2025

Here's Why Schrodinger (SDGR) Is a Great 'Buy the Bottom' Stock Now

Schrodinger (SDGR) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Zacks Investment Research • Nov 10, 2025

Schrödinger to Present at Jefferies London Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced that management will participate in a fireside chat at the Jefferies London Healthcare Conference. The live presentation will take place on Wednesday, November 19, at 4:00 p.m. GMT (11:00 a.m. ET). The live webcast can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming molecular discovery with i.

Business Wire • Nov 6, 2025

Schrödinger, Inc. (SDGR) Q3 2025 Earnings Call Transcript

Schrödinger, Inc. ( SDGR ) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Jaren Madden - Chief Corporate Affairs Officer & Head of Investor Relations Ramy Farid - CEO, President & Director Richie Jain - Executive VP, CFO & Treasurer Karen Akinsanya - President, Head of Therapeutics R&D and Chief Strategy Officer & Partnerships Conference Call Participants Mani Foroohar - Leerink Partners LLC, Research Division Scott Schoenhaus - KeyBanc Capital Markets Inc., Research Division Matthew Hewitt - Craig-Hallum Capital Group LLC, Research Division Conor MacKay - BMO Capital Markets Equity Research Dennis Ding Brendan Smith - TD Cowen, Research Division Michael Ryskin - BofA Securities, Research Division Presentation Operator Thank you for standing by. Welcome to Schrodinger's conference call to review third quarter 2025 financial results.

Seeking Alpha • Nov 6, 2025

Schrödinger Reports Third Quarter 2025 Financial Results

NEW YORK--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced financial results for the quarter ended September 30, 2025. "Schrödinger delivered a solid third quarter with software revenue growth of 28%, reflecting the industry's increasing demand for our leading computational platform,” said Ramy Farid, Ph.D., chief executive officer of Schrödinger. “While we are encouraged by the continued high level of customer engagement as the macroeconomic pressures that have affected the in.

Business Wire • Nov 5, 2025

Schrodinger, Inc. (SDGR) Reports Q3 Loss, Tops Revenue Estimates

Schrodinger, Inc. (SDGR) came out with a quarterly loss of $0.45 per share versus the Zacks Consensus Estimate of a loss of $0.75. This compares to a loss of $0.52 per share a year ago.

Zacks Investment Research • Nov 6, 2025

Copernic Catalysts Announces Achievement of Ammonia Catalyst Milestone in Research Collaboration with Schrödinger

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Copernic Catalysts, Inc. (Copernic) today announced that, in collaboration with Schrödinger, Inc. (Nasdaq: SDGR), the companies have surpassed the final technical milestone for their jointly-developed ammonia synthesis catalyst, branded NeptuneTM. The Neptune catalyst demonstrated an ammonia yield that was over two times higher than that of competing catalysts under real-world reactor environments, achieving the success criteria outlined in the collaboration a.

Business Wire • Oct 30, 2025

Schrödinger to Announce Third Quarter 2025 Financial Results on November 5

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR) will report its third quarter 2025 financial results on Wednesday, November 5, 2025, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. The live webcast can be accessed in the “Investors” section of Schrödinger's website and will be archived for approximately 90 days following the event. About Schrödinger Schrödinger is transforming molecular discovery with its computational platform, whic.

Business Wire • Oct 22, 2025

Strength Seen in Schrodinger (SDGR): Can Its 13.8% Jump Turn into More Strength?

Schrodinger (SDGR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Investment Research • Oct 21, 2025